๐๏ธ Verified NIH Record โข Updated 2025-10-27
Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease (NCT05361382)
Longitudinal Multicenter Head-to-Head Harmonization of Tau PET Tracers
๐ต Active, Not Recruiting Phase1 ๐ Investigational Drug / Biologic Sponsor: Tharick Pascoal
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of this study is to compare/harmonize cross-sectional and longitudinal tau tangle measurements obtained with the tau PET radiopharmaceuticals Flortaucipir and MK-6240 to elucidate the advantages and caveats of their use in clinical trials/practice and provide parameters to integrate their estimates.
Who can join: Review the eligibility criteria below.
Location: Lawrence Berkeley National Laboratory โ Berkeley, California
Age range: 18 Years to 90 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (9 Sites)
- Lawrence Berkeley National Laboratory โ Berkeley, California
- University of California San Francisco โ San Francisco, California
- Mayo Clinic โ Rochester, Minnesota
- Washington University in St. Louis โ St Louis, Missouri
- University of Pittsburgh โ Pittsburgh, Pennsylvania
- Brown University โ Providence, Rhode Island
- Houston Methodist Neurological Institute โ Houston, Texas
- McGill University โ Montreal, Quebec
- Sant Pau Biomedical Research Institute โ Barcelona, Spain
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alzheimer Disease
- The Use of Memantine for Prevention of Alzheimer's Disease โ Charlottesville, Virginia
- Investigation of Inflammation Using [C-11]-CS1P1 โ St Louis, Missouri
- Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia โ Palo Alto, California
- A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) โ Gilbert, Arizona
- High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease โ Cambridge, Massachusetts
- A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease โ Phoenix, Arizona
Explore by condition: All Alzheimer Disease clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.